Ke-Bin Huang

11PUBLICATIONS
12CO-AUTHORS
ChemotherapyNanomaterialsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 30, 2026
Oxoisoaporphine Alkaloid Piano-Stool Arene Ruthenium(II) Derivative: A cGAS-STING-Mediated Chemoimmunotherapy Inducer that Acts as a Dual Catalytic Inhibitor of Topoisomerase I/II.

Liang-Mei Yang, Yuan Lu, Matthew S Levine

|Feb 17, 2026
Beyond Thiol-Enzyme Inhibition: Sterically Bulky NHC-Au(I) Complexes are Catalytically Active Anticancer Agents with Reprogrammed Immunomodulatory Function.

Zhi Zhong, Haitao Liu, Qiong Wu

|Feb 04, 2026
Stable Cyclometalated Gold(III) Complex Engaging Isoquinoline Derivative and Disulfur Ligand Elicits Necroptosis-Dependent Immunogenic Cell Death.

Wei Zhang, Liang-Mei Yang, Yi Zhao

|Jan 12, 2026
Organelle-Targeting Iridium(III) Benzothiazole Complexes Potently Induce Immunogenic Cell Death for Gastric Cancer Immunotherapy.

Hui Jiang, Qiaoshan Lie, Fa Wang

|Oct 22, 2025
Isoquinoline-Derived Half-Sandwich Ru(II) Arene Complex Potentiates Antitumor Chemoimmunotherapeutic Response.

Jing Yang, Ya-Qian Shi, Song He

|Apr 25, 2025
Oxoisoaporphine Alkaloid Iridium(III) Derivative: An Immunogenic Cell Death Inducer That Engages the Autophagy-Dependent Regulator Cathepsin D.

Yuan Lu, Feng-Yang Wang, Matthew S Levine

Pageof 2

Frequent Collaborators

5 joint publications

Taotao Zou

4 joint publications

Ya-Qian Shi

2 joint publications

Hong Liang

2 joint publications

Matthew S Levine